US5877192A
(en)
*
|
1993-05-28 |
1999-03-02 |
Astra Aktiebolag |
Method for the treatment of gastric acid-related diseases and production of medication using (-) enantiomer of omeprazole
|
SE9301830D0
(sv)
*
|
1993-05-28 |
1993-05-28 |
Ab Astra |
New compounds
|
US6875872B1
(en)
|
1993-05-28 |
2005-04-05 |
Astrazeneca |
Compounds
|
DK0723436T3
(da)
*
|
1994-07-08 |
2001-11-26 |
Astrazeneca Ab |
Tabletteret flerenhedsdoseringsform
|
SE504459C2
(sv)
*
|
1994-07-15 |
1997-02-17 |
Astra Ab |
Förfarande för framställning av substituerade sulfoxider
|
SE9500422D0
(sv)
*
|
1995-02-06 |
1995-02-06 |
Astra Ab |
New oral pharmaceutical dosage forms
|
SE9500478D0
(sv)
*
|
1995-02-09 |
1995-02-09 |
Astra Ab |
New pharmaceutical formulation and process
|
HRP960232A2
(en)
*
|
1995-07-03 |
1998-02-28 |
Astra Ab |
A process for the optical purification of compounds
|
US6699885B2
(en)
*
|
1996-01-04 |
2004-03-02 |
The Curators Of The University Of Missouri |
Substituted benzimidazole dosage forms and methods of using same
|
US6645988B2
(en)
*
|
1996-01-04 |
2003-11-11 |
Curators Of The University Of Missouri |
Substituted benzimidazole dosage forms and method of using same
|
US5840737A
(en)
|
1996-01-04 |
1998-11-24 |
The Curators Of The University Of Missouri |
Omeprazole solution and method for using same
|
US6489346B1
(en)
|
1996-01-04 |
2002-12-03 |
The Curators Of The University Of Missouri |
Substituted benzimidazole dosage forms and method of using same
|
SE9600070D0
(sv)
|
1996-01-08 |
1996-01-08 |
Astra Ab |
New oral pharmaceutical dosage forms
|
SE508669C2
(sv)
*
|
1996-04-26 |
1998-10-26 |
Astra Ab |
Nytt förfarande
|
SE510666C2
(sv)
*
|
1996-12-20 |
1999-06-14 |
Astra Ab |
Nya Kristallmodifikationer
|
SE9702000D0
(sv)
*
|
1997-05-28 |
1997-05-28 |
Astra Ab |
New pharmaceutical formulation
|
US6747155B2
(en)
|
1997-05-30 |
2004-06-08 |
Astrazeneca Ab |
Process
|
SE510650C2
(sv)
*
|
1997-05-30 |
1999-06-14 |
Astra Ab |
Ny förening
|
SE510643C2
(sv)
*
|
1997-06-27 |
1999-06-14 |
Astra Ab |
Termodynamiskt stabil omeprazol natrium form B
|
US6174548B1
(en)
|
1998-08-28 |
2001-01-16 |
Andrx Pharmaceuticals, Inc. |
Omeprazole formulation
|
US6096340A
(en)
|
1997-11-14 |
2000-08-01 |
Andrx Pharmaceuticals, Inc. |
Omeprazole formulation
|
ATE260090T1
(de)
*
|
1997-12-08 |
2004-03-15 |
Altana Pharma Ag |
Neue suppositoriumsform mit säureempfindliche wirkstoffe
|
SE9704870D0
(sv)
*
|
1997-12-22 |
1997-12-22 |
Astra Ab |
New pharmaceutical formulation I
|
SE9704869D0
(sv)
*
|
1997-12-22 |
1997-12-22 |
Astra Ab |
New pharmaceutical formulaton II
|
CN1141097C
(zh)
*
|
1998-04-20 |
2004-03-10 |
卫材株式会社 |
含有稳定化的苯并咪唑类化合物的组合物
|
NZ510180A
(en)
|
1998-08-10 |
2002-11-26 |
Univ California |
Prodrugs of the pyridyl-methylsulphonyl-benzimidazole type proton pump inhibitors
|
US6733778B1
(en)
|
1999-08-27 |
2004-05-11 |
Andrx Pharmaceuticals, Inc. |
Omeprazole formulation
|
SE9803772D0
(sv)
|
1998-11-05 |
1998-11-05 |
Astra Ab |
Pharmaceutical formulation
|
BR9915421A
(pt)
|
1998-11-18 |
2001-08-07 |
Astrazeneca Ab |
Processo para a fabricação de sais alcalinos levemente solúveis ou menos solúveis de heterociclos de sulfinila substituìda, forma de dosagem farmacêutica, uso da mesma, método de tratamento de doenças gastrointestinais, e, processo para a fabricação de uma forma de dosagem farmacêutica.
|
SE9900274D0
(sv)
*
|
1999-01-28 |
1999-01-28 |
Astra Ab |
New compound
|
US6852739B1
(en)
*
|
1999-02-26 |
2005-02-08 |
Nitromed Inc. |
Methods using proton pump inhibitors and nitric oxide donors
|
TWI243672B
(en)
|
1999-06-01 |
2005-11-21 |
Astrazeneca Ab |
New use of compounds as antibacterial agents
|
WO2000076556A2
(en)
*
|
1999-06-11 |
2000-12-21 |
Neorx Corporation |
High dose radionuclide complexes for bone marrow suppression
|
US7094885B2
(en)
*
|
1999-07-11 |
2006-08-22 |
Neorx Corporation |
Skeletal-targeted radiation to treat bone-associated pathologies
|
US6326384B1
(en)
|
1999-08-26 |
2001-12-04 |
Robert R. Whittle |
Dry blend pharmaceutical unit dosage form
|
US6262086B1
(en)
|
1999-08-26 |
2001-07-17 |
Robert R. Whittle |
Pharmaceutical unit dosage form
|
US6369087B1
(en)
|
1999-08-26 |
2002-04-09 |
Robert R. Whittle |
Alkoxy substituted benzimidazole compounds, pharmaceutical preparations containing the same, and methods of using the same
|
US6780880B1
(en)
|
1999-08-26 |
2004-08-24 |
Robert R. Whittle |
FT-Raman spectroscopic measurement
|
US6312712B1
(en)
|
1999-08-26 |
2001-11-06 |
Robert R. Whittle |
Method of improving bioavailability
|
US6262085B1
(en)
|
1999-08-26 |
2001-07-17 |
Robert R. Whittle |
Alkoxy substituted Benzimidazole compounds, pharmaceutical preparations containing the same, and methods of using the same
|
US6312723B1
(en)
|
1999-08-26 |
2001-11-06 |
Robert R. Whittle |
Pharmaceutical unit dosage form
|
US6316020B1
(en)
*
|
1999-08-26 |
2001-11-13 |
Robert R. Whittle |
Pharmaceutical formulations
|
US6268385B1
(en)
|
1999-08-26 |
2001-07-31 |
Robert R. Whittle |
Dry blend pharmaceutical formulations
|
EP1595879A3
(en)
*
|
1999-08-26 |
2010-01-27 |
aaiPharma Inc. |
Alkoxy substituted benzimidazole compounds, pharmaceutical preparations containing the same, and methods of using the same
|
AU2878801A
(en)
*
|
1999-10-01 |
2001-05-10 |
Natco Pharma Limited |
An improved pharmaceutical composition and a process for its preparation
|
DE60036014T2
(de)
*
|
1999-10-20 |
2008-04-30 |
Eisai R&D Management Co., Ltd. |
Methode zur stabilisierung von benzimidazol-verbindungen
|
SE9903831D0
(sv)
|
1999-10-22 |
1999-10-22 |
Astra Ab |
Formulation of substituted benzimidazoles
|
PT1257269E
(pt)
|
2000-02-24 |
2005-03-31 |
Kopran Res Lab Ltd |
Derivados do benzimidazole anti-ulcera estavel em relacao ao acido de administracao oral
|
SE0000774D0
(sv)
|
2000-03-08 |
2000-03-08 |
Astrazeneca Ab |
New formulation
|
EP1706397A4
(en)
*
|
2000-05-15 |
2007-08-01 |
Ranbaxy Lab Ltd |
AMORPHOUS FORM OF OMEPRAZOLE SALTS
|
US6306435B1
(en)
*
|
2000-06-26 |
2001-10-23 |
Yung Shin Pharmaceutical Industrial Co. Ltd. |
Oral pharmaceutical preparation embedded in an oily matrix and methods of making the same
|
CA2417311C
(en)
|
2000-08-04 |
2012-07-10 |
Takeda Chemical Industries, Ltd. |
Crystalline alkali metal salts of lansoprazole and their production and use
|
CA2386716C
(en)
*
|
2002-05-17 |
2012-07-24 |
Bernard Charles Sherman |
Magnesium salt of s-omeprazole
|
AU2003204233B8
(en)
*
|
2000-08-04 |
2008-06-26 |
Bernard Charles Sherman |
Magnesium salt of S-omeprazole
|
US6544556B1
(en)
|
2000-09-11 |
2003-04-08 |
Andrx Corporation |
Pharmaceutical formulations containing a non-steroidal antiinflammatory drug and a proton pump inhibitor
|
AU2001296908A1
(en)
*
|
2000-09-29 |
2002-04-08 |
Geneva Pharmaceuticals, Inc. |
Proton pump inhibitor formulation
|
WO2002062398A2
(en)
|
2001-01-08 |
2002-08-15 |
Neorx Corporation |
Radioactively labelled conjugates of phosphonates
|
US7064214B2
(en)
*
|
2001-04-13 |
2006-06-20 |
Apsinterm Llc |
Methods of preparing sulfinamides and sulfoxides
|
SE0101379D0
(sv)
|
2001-04-18 |
2001-04-18 |
Diabact Ab |
Komposition som hämmar utsöndring av magsyra
|
US8206741B2
(en)
|
2001-06-01 |
2012-06-26 |
Pozen Inc. |
Pharmaceutical compositions for the coordinated delivery of NSAIDs
|
GB2376231A
(en)
|
2001-06-06 |
2002-12-11 |
Cipla Ltd |
Benzimidazole-cyclodextrin inclusion complex
|
SE0102993D0
(sv)
|
2001-09-07 |
2001-09-07 |
Astrazeneca Ab |
New self emulsifying drug delivery system
|
JP4020076B2
(ja)
|
2001-09-18 |
2007-12-12 |
ゼリア新薬工業株式会社 |
ベンズイミダゾール誘導体
|
EP1469839A2
(en)
*
|
2002-01-25 |
2004-10-27 |
Santarus, Inc. |
Transmucosal delivery of proton pump inhibitors
|
ES2286408T3
(es)
*
|
2002-03-05 |
2007-12-01 |
Astrazeneca Ab |
Sales de alquilamonio de omeprazol e esomeprazol.
|
US7906145B2
(en)
|
2002-04-09 |
2011-03-15 |
Flamel Technologies |
Oral pharmaceutical formulation in the form of aqueous suspension for modified release of active principle(s)
|
US6894066B2
(en)
*
|
2002-05-09 |
2005-05-17 |
Bernard Charles Sherman |
Magnesium salt of S-omeprazole
|
JP4463103B2
(ja)
*
|
2002-07-19 |
2010-05-12 |
ウィンストン・ファーマシューティカルズ・リミテッド・ライアビリティ・カンパニー |
ベンズイミダゾール誘導体およびプロトンポンプ阻害剤のプロドラッグとしてのその使用
|
TW200410955A
(en)
*
|
2002-07-29 |
2004-07-01 |
Altana Pharma Ag |
Novel salt of (S)-PANTOPRAZOLE
|
US7211590B2
(en)
*
|
2002-08-01 |
2007-05-01 |
Nitromed, Inc. |
Nitrosated proton pump inhibitors, compositions and methods of use
|
EP1546131A1
(en)
|
2002-08-30 |
2005-06-29 |
Dr. Reddy's Laboratories Ltd. |
Amorphous hydrates of esomeprazole magnesium and process for the preparation thereof
|
EP2596792A1
(en)
|
2002-10-16 |
2013-05-29 |
Takeda Pharmaceutical Company Limited |
Stable solid preparations
|
SE0203065D0
(sv)
|
2002-10-16 |
2002-10-16 |
Diabact Ab |
Gastric acid secretion inhibiting composition
|
EP1556043A1
(en)
*
|
2002-10-22 |
2005-07-27 |
Ranbaxy Laboratories, Ltd. |
Amorphous form of esomeprazole salts
|
US20040242642A1
(en)
*
|
2002-11-18 |
2004-12-02 |
Dr. Reddy's Laboratories Limited |
Crystalline esomeprazole compounds and process for the preparation thereof
|
DE10254167A1
(de)
|
2002-11-20 |
2004-06-09 |
Icon Genetics Ag |
Verfahren zur Kontrolle von zellulären Prozessen in Pflanzen
|
CA2507807C
(en)
|
2002-12-06 |
2013-10-22 |
Altana Pharma Ag |
Process for preparing optically pure proton pump inhibitors
|
SI1575941T1
(sl)
|
2002-12-06 |
2012-08-31 |
Nycomed Gmbh |
Postopek za pripravo (S)-pantoprazola
|
FR2848555B1
(fr)
|
2002-12-16 |
2006-07-28 |
Negma Gild |
Enantiomere(-)du tenatoprazole et son application en therapeutique
|
WO2004066924A2
(en)
*
|
2003-01-24 |
2004-08-12 |
Andrx Labs Llc |
Novel pharmaceutical formulation containing a proton pump inhibitor and an antacid
|
JP2006518751A
(ja)
*
|
2003-02-20 |
2006-08-17 |
サンタラス インコーポレイティッド |
胃酸の急速かつ持続的な抑制のための新規製剤、オメプラゾール制酸剤複合体−即時放出物
|
RU2005129513A
(ru)
*
|
2003-02-28 |
2006-03-10 |
Рэнбакси Лабораториз Лимитед (In) |
Полиморфы s-омепразола
|
WO2004089935A1
(en)
*
|
2003-04-10 |
2004-10-21 |
Hetero Drugs Limitd |
Novel crystalline forms of s-omeprazole magnesium
|
WO2004099181A1
(en)
*
|
2003-05-05 |
2004-11-18 |
Ranbaxy Laboratories Limited |
Barium salt of benzimidazole derivative
|
WO2004099182A1
(en)
*
|
2003-05-05 |
2004-11-18 |
Ranbaxy Laboratories Limited |
Zinc salt of (s)-omeprazole
|
KR20060041224A
(ko)
*
|
2003-07-15 |
2006-05-11 |
알러간, 인코포레이티드 |
양성자 펌프 억제제의 이성질체적으로 순수한 프로드러그를제조하는 방법
|
US8993599B2
(en)
|
2003-07-18 |
2015-03-31 |
Santarus, Inc. |
Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
|
CA2531564C
(en)
*
|
2003-07-18 |
2016-01-19 |
Santarus, Inc. |
Pharmaceutical composition for inhibiting acid secretion
|
TWI337877B
(en)
*
|
2003-07-18 |
2011-03-01 |
Santarus Inc |
Pharmaceutical formulation and method for treating acid-caused gastrointestinal disorders
|
ES2302007T3
(es)
*
|
2003-07-23 |
2008-07-01 |
Nycomed Gmbh |
Sales alcalinas de inhibidores de la bomba de protones.
|
CN100457104C
(zh)
*
|
2003-07-23 |
2009-02-04 |
尼科梅德有限责任公司 |
质子泵抑制剂的碱性盐
|
US20060165793A1
(en)
*
|
2003-08-04 |
2006-07-27 |
Koji Ukai |
Pharmaceutical preparation to be dispersed before administration
|
SE0302382D0
(sv)
*
|
2003-09-04 |
2003-09-04 |
Astrazeneca Ab |
New salts II
|
SE0302381D0
(sv)
*
|
2003-09-04 |
2003-09-04 |
Astrazeneca Ab |
New salts I
|
EP1663173A1
(en)
*
|
2003-09-25 |
2006-06-07 |
Natco Pharma Limited |
Enteric soft gelatin capsule containing esomeprazole and method of preparation
|
AU2004314693B2
(en)
|
2003-09-26 |
2011-04-07 |
Alza Corporation |
Drug coating providing high drug loading and methods for providing the same
|
US20050075371A1
(en)
*
|
2003-10-03 |
2005-04-07 |
Allergan, Inc. |
Methods and compositions for the oral administration of prodrugs of proton pump inhibitors
|
WO2005034924A1
(en)
*
|
2003-10-14 |
2005-04-21 |
Natco Pharma Limited |
Enteric coated pellets comprising esomeprazole, hard gelatin capsule containing them, and method of preparation
|
GB0403165D0
(en)
*
|
2004-02-12 |
2004-03-17 |
Ct |
Novel uses for proton pump inhibitors
|
WO2005082337A2
(en)
*
|
2004-02-18 |
2005-09-09 |
Allergan, Inc. |
Compositions comprising prodrugs of proton pump inhibitors
|
BRPI0507837A
(pt)
*
|
2004-02-18 |
2007-07-10 |
Allergan Inc |
métodos e composições para a administração intravenosa de compostos relacionados a inibidores de bomba de prótons
|
SE0400410D0
(sv)
|
2004-02-20 |
2004-02-20 |
Astrazeneca Ab |
New compounds
|
WO2005082888A1
(en)
*
|
2004-03-01 |
2005-09-09 |
Milen Merkez Ilac Endustrisi A.S. |
Process for the preparation of magnesium salt of omeprazole
|
PT1740571E
(pt)
|
2004-04-28 |
2009-09-02 |
Hetero Drugs Ltd |
Processo para preparar compostos de piridinilmetil-1hbenzimidazol na forma enantiomericamente enriquecida ou como enantiómeros únicos
|
US8815916B2
(en)
|
2004-05-25 |
2014-08-26 |
Santarus, Inc. |
Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
|
US8906940B2
(en)
|
2004-05-25 |
2014-12-09 |
Santarus, Inc. |
Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
|
US7365206B2
(en)
*
|
2004-05-28 |
2008-04-29 |
Hetero Drugs Limited |
Stereoselective synthesis of benzimidazole sulfoxides
|
US20050267159A1
(en)
*
|
2004-05-28 |
2005-12-01 |
Aaipharma, Inc. |
Magnesium complexes of S-omeprazole
|
US20050267157A1
(en)
*
|
2004-05-28 |
2005-12-01 |
David White |
Magnesium-S-omeprazole
|
US20080249134A1
(en)
*
|
2004-06-24 |
2008-10-09 |
Ursula Hohlneicher |
New Esomeprazole Sodium Salt Crystal Modification
|
CA2570795C
(en)
*
|
2004-06-24 |
2013-05-28 |
Astrazeneca Ab |
Process for the preparation of crystal modifications for use in the preparation of esomeprazole sodium salt
|
US20060024362A1
(en)
|
2004-07-29 |
2006-02-02 |
Pawan Seth |
Composition comprising a benzimidazole and process for its manufacture
|
KR100847635B1
(ko)
*
|
2004-08-06 |
2008-07-21 |
에자이 알앤드디 매니지먼트 가부시키가이샤 |
벤즈이미다졸 유도체와 아민과의 염
|
WO2006013960A1
(ja)
|
2004-08-06 |
2006-02-09 |
Eisai R & D Management Co., Ltd. |
ベンズイミダゾール誘導体とアミンとの塩およびその製造方法
|
US8541026B2
(en)
|
2004-09-24 |
2013-09-24 |
Abbvie Inc. |
Sustained release formulations of opioid and nonopioid analgesics
|
EP1830822A1
(en)
*
|
2004-12-24 |
2007-09-12 |
LEK Pharmaceuticals D.D. |
Stable pharmaceutical composition comprising an active substance in the form of solid solution
|
WO2006073779A1
(en)
*
|
2004-12-30 |
2006-07-13 |
Transform Phamaceuticals, Inc. |
Novel omeprazole forms and related methods
|
ES2259269B1
(es)
|
2005-03-03 |
2007-11-01 |
Esteve Quimica, S.A. |
Procedimiento para la preparacion de derivados de 2-(2-piridilmetilsulfinil)-bencimidazol opticamente activos.
|
ATE528301T1
(de)
|
2005-03-25 |
2011-10-15 |
Livzon Pharmaceutical Group |
Verfahren zur herstellung von substituierten sulfoxidzusammensetzungen
|
US20090298884A1
(en)
*
|
2005-05-06 |
2009-12-03 |
Glenmark Generics Ltd. |
Esomeprazole Strontium Salt, Process For Its Preparation and Pharmaceutical Compositions Containing Same
|
CA2607953A1
(en)
*
|
2005-05-09 |
2006-11-16 |
Tap Pharmaceutical Products, Inc. |
Methods for treating nephrolithiasis
|
US7803817B2
(en)
|
2005-05-11 |
2010-09-28 |
Vecta, Ltd. |
Composition and methods for inhibiting gastric acid secretion
|
US7981908B2
(en)
|
2005-05-11 |
2011-07-19 |
Vecta, Ltd. |
Compositions and methods for inhibiting gastric acid secretion
|
WO2006134605A1
(en)
*
|
2005-06-15 |
2006-12-21 |
Hetero Drugs Limited |
Amorphous esomeprazole hydrate
|
KR100641534B1
(ko)
*
|
2005-07-28 |
2006-11-01 |
한미약품 주식회사 |
에스오메프라졸 및 그의 염의 제조방법
|
WO2007019153A2
(en)
*
|
2005-08-03 |
2007-02-15 |
Tap Pharmaceutical Products, Inc. |
Methods for treating hypertension
|
US20070043085A1
(en)
*
|
2005-08-19 |
2007-02-22 |
Glenmark Pharmaceuticals Limited |
Process for the preparation of amorphous form of neutral esomeprazole
|
WO2007031845A2
(en)
*
|
2005-09-14 |
2007-03-22 |
Glenmark Pharmaceuticals Limited |
Polymorphic forms of (s)-omeprazole magnesium salts and processes for their preparation
|
US7598273B2
(en)
*
|
2005-10-06 |
2009-10-06 |
Auspex Pharmaceuticals, Inc |
Inhibitors of the gastric H+, K+-ATPase with enhanced therapeutic properties
|
US7576219B2
(en)
|
2005-10-26 |
2009-08-18 |
Hanmi Pharm. Co., Ltd |
Crystalline S-omeprazole strontium hydrate, method for preparing same, and pharmaceutical composition containing same
|
WO2007067128A1
(en)
|
2005-12-05 |
2007-06-14 |
Astrazeneca Ab |
New process for the preparation of esomeprazole non-salt form
|
EP1801110A1
(en)
|
2005-12-22 |
2007-06-27 |
KRKA, tovarna zdravil, d.d., Novo mesto |
Esomeprazole arginine salt
|
US7553857B2
(en)
|
2005-12-23 |
2009-06-30 |
Lek Pharmaceuticals D.D. |
S-omeprazole magnesium
|
DE602006006352D1
(de)
*
|
2005-12-28 |
2009-05-28 |
Union Quimico Farma |
Verfahren zur herstellung des (s)-enantiomers von omeprazol
|
US8063074B2
(en)
|
2006-05-04 |
2011-11-22 |
Dr. Reddy's Laboratories Limited |
Polymorphic forms of esomeprazole sodium
|
DE602007010926D1
(de)
*
|
2006-06-07 |
2011-01-13 |
Astrazeneca Ab |
Neues verfahren zur herstellung von ammoniumsalzen von esomeprazol
|
US7863330B2
(en)
|
2006-06-14 |
2011-01-04 |
Rottapharm S.P.A. |
Deloxiglumide and proton pump inhibitor combination in the treatment of gastrointestinal disorders
|
US8404853B2
(en)
|
2006-07-05 |
2013-03-26 |
Lupin Limited |
Process for the preparation of optically pure or optically enriched enantiomers of sulphoxide compounds
|
RU2467747C2
(ru)
|
2006-07-25 |
2012-11-27 |
Векта Лтд. |
Композиции и способы для ингибирования секреции желудочной кислоты с использованием производных малых дикарбоновых кислот в сочетании с ppi
|
WO2008036201A1
(en)
*
|
2006-09-19 |
2008-03-27 |
Alevium Pharmaceuticals, Inc. |
Prodrugs of proton pump inhibitors including the 1h-imidazo[4,5-b] pyridine moiety
|
EP2068841B1
(en)
|
2006-10-05 |
2018-09-26 |
Santarus, Inc. |
Novel formulations of proton pump inhibitors and methods of using these formulations
|
US20090092658A1
(en)
*
|
2007-10-05 |
2009-04-09 |
Santarus, Inc. |
Novel formulations of proton pump inhibitors and methods of using these formulations
|
EP2486910A3
(en)
|
2006-10-27 |
2012-08-22 |
The Curators Of The University Of Missouri |
Multi-chambered apparatus comprising a dispenser head
|
EP2101761A4
(en)
*
|
2006-11-13 |
2010-01-27 |
Takeda Pharmaceuticals North A |
METHODS FOR PRESERVING RENAL FUNCTION USING XANTHINE OXYDOREDUCTASE INHIBITORS
|
US20090124623A1
(en)
*
|
2006-11-13 |
2009-05-14 |
Christopher Lademacher |
Methods for preserving and/or increasing renal function using xanthine oxidoreductase inhibitors
|
EP1947099A1
(en)
|
2007-01-18 |
2008-07-23 |
LEK Pharmaceuticals D.D. |
Process for solvent removal from omeprazole salts
|
US20090042887A1
(en)
*
|
2007-01-19 |
2009-02-12 |
Tap Pharmaceutical Products, Inc. |
Methods for Preventing or Reducing the Number of Gout Flares Using Xanthine Oxidoreductase Inhibitors and Anti-Inflammatory Agents
|
EP2114919A2
(en)
*
|
2007-01-31 |
2009-11-11 |
Krka Tovarna Zdravil, D.D., Novo Mesto |
Process for the preparation of optically pure omeprazole via salt formation with a chiral amine or treatment with an entiomer converting enzyme and chromatographic seperation
|
US20080194307A1
(en)
*
|
2007-02-13 |
2008-08-14 |
Jeff Sanger |
Sports-based game of chance
|
EP2186807B1
(en)
|
2007-02-21 |
2015-01-07 |
Cipla Limited |
Process for the preparation of esomeprazole magnesium dihydrate
|
KR101303813B1
(ko)
*
|
2007-04-16 |
2013-09-04 |
에스케이케미칼주식회사 |
라세믹 오메프라졸로부터 에스오메프라졸의 개선된제조방법
|
EP2000468A1
(en)
*
|
2007-05-09 |
2008-12-10 |
Dr. Reddy's Laboratories Ltd. |
Esomeprazole salts and processes for preparation thereof
|
EP2152691B1
(en)
*
|
2007-06-07 |
2011-11-23 |
Aurobindo Pharma Limited |
An improved process for preparing an optically active proton pump inhibitor
|
CN101323609B
(zh)
*
|
2007-06-15 |
2013-05-01 |
成都福瑞生物工程有限公司 |
不对称氧化硫醚成亚砜合成对映体含量高的苯并咪唑衍生物的方法
|
US7947840B2
(en)
|
2007-09-25 |
2011-05-24 |
Hetero Drugs Limited |
Process for preparation of enantiomerically pure esomeprazole
|
EP2195309A4
(en)
*
|
2007-10-08 |
2013-04-24 |
Hetero Drugs Ltd |
SALT POLYMORPHS OF THE ESOMEPRAZOLE
|
FR2925899B1
(fr)
*
|
2007-12-27 |
2012-12-21 |
Sidem Pharma Sa |
Procede de preparation enantioselective de sulfoxydes.
|
US8247440B2
(en)
|
2008-02-20 |
2012-08-21 |
Curators Of The University Of Missouri |
Composition comprising omeprazole, lansoprazole and at least one buffering agent
|
US20090280175A1
(en)
*
|
2008-05-09 |
2009-11-12 |
Ishwar Chauhan |
Multilayer Proton Pump Inhibitor Tablets
|
US20090280173A1
(en)
*
|
2008-05-09 |
2009-11-12 |
Ishwar Chauhan |
Multilayer Omeprazole Tablets
|
WO2009145368A1
(en)
*
|
2008-05-27 |
2009-12-03 |
Sk Chemicals Co., Ltd. |
Improved preparing method of (s)-omeprazole from omeprazole racemate using optical resolution agent
|
EP2143722A1
(en)
*
|
2008-07-09 |
2010-01-13 |
Lek Pharmaceuticals D.D. |
Process for preparation of esomeprazole sodium of high chemical purity and new forms of esomeprazole sodium
|
EP2147918A1
(en)
|
2008-07-21 |
2010-01-27 |
LEK Pharmaceuticals D.D. |
Process for the preparation of S-omeprazole magnesium in a stable form
|
BRPI0918492A2
(pt)
|
2008-09-09 |
2015-12-01 |
Astrazeneca Ab |
uso de naproxen, ou sal farmaceuticamente aceitável do mesmo, e esomeprazol, ou sal farmaceuticamente aceitável do mesmo
|
EP2264024A1
(en)
|
2008-10-14 |
2010-12-22 |
LEK Pharmaceuticals d.d. |
Process for the preparation of enantiomerically enriched proton pump inhibitors
|
WO2010058409A2
(en)
|
2008-11-18 |
2010-05-27 |
Hetero Research Foundation |
Optical purification of esomeprazole
|
US20100311756A1
(en)
*
|
2009-01-22 |
2010-12-09 |
Takeda Pharmaceuticals North America, Inc. |
Methods for delaying the progression of at least one of cardiac hypertrophy, cardiac remodeling or left ventricular function or the onset of heart failure in subjects in need of treatment thereof
|
WO2010097583A1
(en)
|
2009-02-24 |
2010-09-02 |
Cipla Limited |
Esomeprazole potassium polymorph and its preparation
|
EP2445344A4
(en)
*
|
2009-06-25 |
2013-01-23 |
Pozen Inc |
METHOD FOR THE TREATMENT OF A PATIENT REQUIRED BY ASPIRIN THERAPY
|
SG176724A1
(en)
|
2009-06-25 |
2012-01-30 |
Astrazeneca Ab |
Method for treating a patient at risk for developing an nsaid-associated ulcer
|
EP2319504A1
(en)
|
2009-11-07 |
2011-05-11 |
Laboratorios Del. Dr. Esteve, S.A. |
Pharmaceutical solid dosage form
|
WO2011058569A1
(en)
|
2009-11-12 |
2011-05-19 |
Hetero Research Foundation |
Process for the resolution of omeprazole
|
WO2011080500A2
(en)
|
2009-12-29 |
2011-07-07 |
Orexo Ab |
New pharmaceutical dosage form for the treatment of gastric acid-related disorders
|
WO2011080501A2
(en)
|
2009-12-29 |
2011-07-07 |
Orexo Ab |
New pharmaceutical dosage form for the treatment of gastric acid-related disorders
|
WO2011080502A2
(en)
|
2009-12-29 |
2011-07-07 |
Orexo Ab |
New pharmaceutical dosage form for the treatment of gastric acid-related disorders
|
EP2345408A3
(en)
|
2010-01-08 |
2012-02-29 |
Dr. Reddy's Laboratories Ltd. |
Acid labile drug formulations
|
JP5714031B2
(ja)
|
2010-02-12 |
2015-05-07 |
エステヴェ キミカ, エス.エー. |
エソメプラゾールナトリウムのナトリウム塩の調製方法
|
US20110207779A1
(en)
*
|
2010-02-25 |
2011-08-25 |
Glenmark Generics Ltd |
Process for the preparation of esomeprazole magnesium
|
ES2532210T3
(es)
|
2010-09-10 |
2015-03-25 |
Takeda Pharmaceuticals U.S.A., Inc. |
Métodos para el tratamiento concomitante de teofilina y febuxostat
|
CN102816149B
(zh)
*
|
2011-06-10 |
2015-05-13 |
上海汇伦生命科技有限公司 |
一种高对映选择性合成(s)-奥美拉唑及其盐的制备方法
|
CN102807561A
(zh)
*
|
2011-06-21 |
2012-12-05 |
寿光富康制药有限公司 |
S-奥美拉唑铝盐及其制备方法和应用
|
CN102850323A
(zh)
*
|
2011-06-30 |
2013-01-02 |
秦引林 |
一种埃索美拉唑钠的精制方法
|
CN102321071B
(zh)
*
|
2011-07-20 |
2013-01-23 |
江苏奥赛康药业股份有限公司 |
一种高纯度埃索美拉唑钠的工业化生产方法
|
CN102911158B
(zh)
*
|
2011-07-31 |
2015-07-22 |
连云港润众制药有限公司 |
埃索美拉唑镁的晶型
|
WO2013081566A1
(en)
|
2011-11-25 |
2013-06-06 |
Mahmut Bilgic |
A formulation comprising benzimidazole
|
EP2601947A1
(en)
|
2011-12-05 |
2013-06-12 |
Abo Bakr Mohammed Ali Al-Mehdar |
Fixed-dose combination for treatment of helicobacter pylori associated diseases
|
BR112014014558A8
(pt)
|
2011-12-16 |
2017-07-04 |
Atopix Therapeutics Ltd |
composição farmacêutica, uso de um antagonista de crth2 e de um inibidor de bomba de prótons, e, kit para o tratamento de esofagite eosinofílica
|
US9539214B2
(en)
|
2011-12-28 |
2017-01-10 |
Pozen Inc. |
Compositions and methods for delivery of omeprazole plus acetylsalicylic acid
|
WO2013108068A1
(en)
|
2012-01-21 |
2013-07-25 |
Jubilant Life Sciences Limited |
Process for the preparation of 2-pyridinylmethylsulfinyl benzimidazoles, their analogs and optically active enantiomers
|
CN103420978A
(zh)
*
|
2012-05-15 |
2013-12-04 |
上海医药工业研究院 |
一种苯并咪唑类化合物的镁盐的制备方法
|
CN102657622A
(zh)
*
|
2012-05-17 |
2012-09-12 |
康普药业股份有限公司 |
一种含有埃索美拉唑钠的冻干粉针剂的制备工艺
|
CN102964335B
(zh)
*
|
2012-11-13 |
2014-06-25 |
凌元敏 |
一种埃索美拉唑钠化合物及其制备方法和用途
|
CN103159737B
(zh)
*
|
2013-04-12 |
2014-03-19 |
四川省惠达药业有限公司 |
一种埃索美拉唑钠化合物及药物组合物
|
US20160256399A1
(en)
|
2013-11-04 |
2016-09-08 |
Capsugel Belgium Nv |
Methods and systems for improved bioavailability of active pharmaceutical ingredients including esomeprazole
|
WO2015155281A1
(en)
|
2014-04-11 |
2015-10-15 |
Sanovel Ilac Sanayi Ve Ticaret A.S. |
Pharmaceutical combinations of dabigatran and proton pump inhibitors
|
EP2929885A1
(en)
|
2014-04-11 |
2015-10-14 |
Sanovel Ilac Sanayi ve Ticaret A.S. |
Pharmaceutical combinations of rivaroxaban and proton pump inhibitors
|
CN104045627A
(zh)
*
|
2014-05-21 |
2014-09-17 |
丽珠医药集团股份有限公司 |
一种奥美拉唑纯化方法
|
CN104530003A
(zh)
*
|
2014-06-10 |
2015-04-22 |
广东东阳光药业有限公司 |
吡啶甲基亚磺酰基-1h-苯并咪唑类化合物的盐的制备方法
|
EP2980086B1
(en)
|
2014-07-29 |
2016-06-15 |
F.I.S.- Fabbrica Italiana Sintetici S.p.A. |
Efficient process for the preparation of esomeprazole (S)-binol complex
|
JP6548336B2
(ja)
|
2014-12-26 |
2019-07-24 |
国立大学法人 東京大学 |
光学活性のプロトンポンプ阻害化合物の製造方法
|
ES2615637T3
(es)
|
2015-03-06 |
2017-06-07 |
F.I.S.- Fabbrica Italiana Sintetici S.P.A. |
Procedimiento mejorado para la purificación óptica del esomeprazol
|
US10736855B2
(en)
|
2016-02-25 |
2020-08-11 |
Dexcel Pharma Technologies Ltd. |
Compositions comprising proton pump inhibitors
|
CN105924430A
(zh)
*
|
2016-06-27 |
2016-09-07 |
杭州富阳伟文环保科技有限公司 |
一种埃索美拉唑钠的精制方法
|
US10939686B2
(en)
*
|
2017-04-11 |
2021-03-09 |
Mclaughlin Gormley King Company |
Sabadilla oil and uses thereof
|
CN108409714A
(zh)
*
|
2018-03-29 |
2018-08-17 |
成都通德药业有限公司 |
埃索美拉唑、埃索美拉唑盐及埃索美拉唑镁的制备方法
|
CN114364371A
(zh)
*
|
2019-07-16 |
2022-04-15 |
金德雷德生物科学股份有限公司 |
马科动物埃索美拉唑配制品及其用途
|
EP4015044B1
(en)
|
2019-08-29 |
2024-05-29 |
Tokyo University of Science Foundation |
Method for preparing enantiomer of sulfoxide compound, and system for preparing enantiomer
|
RU2726320C1
(ru)
*
|
2020-02-09 |
2020-07-13 |
Федеральное государственное бюджетное образовательное учреждение высшего образования "Кемеровский государственный медицинский университет" Министерства здравоохранения Российской Федерации (ФГБОУ ВО КемГМУ) |
Способ определения примесных компонентов омепразола
|
WO2024075017A1
(en)
|
2022-10-04 |
2024-04-11 |
Zabirnyk Arsenii |
Inhibition of aortic valve calcification
|